Researchers have learned more about genetic changes in cells that cause cancer and have developed drugs that target these changes. New therapies called “targeted therapies” have been developed. These therapies help keep cancer from growing and spreading by targeting the specific genetic variant in your tumor. Understanding the molecular profile of your tumor can help identify the therapy that is most likely to work for you.
Access to the appropriate targeted therapy for your cancer type can help personalize your treatment plan. OmniSeq® provides the molecular testing that can improve treatment outcomes by identifying the targeted cancer therapy that is applicable for you. The molecular test, OmniSeq Comprehensive℠, works to find the specific mutation within a patient’s genes so that doctors can develop a treatment plan that works precisely for that mutation.
OmniSeq’s mission is to identify the right drug or the right clinical trial for every patient. Our dedicated OmniSeq CARES℠ team of specialists will help you and your doctor identify the right treatment plan.
Speak with your doctor today about how OmniSeq Comprehensive can help
OmniSeq CARES Service Program
Let’s work together to
get the support you deserve.
OmniSeq CARES guides Comprehensive cancer care through helping patients with Access to information about targeted therapy, Resources for financial support, Enrollment in clinical trials, and Service that is unmatched in the industry.
OmniSeq understands the many challenges that you face in your fight against cancer. OmniSeq CARES is dedicated to minimizing the financial burden placed upon patients. OmniSeq actively works with insurance carriers to maximize insurance coverage of OmniSeq testing.
Clinical Trial Navigation
OmniSeq is your dedicated clinical trial access partner and will help connect you to clinical trials that are most appropriate for you based on the clinical characteristics of your cancer and molecular profile.
Interest-Free Financial Assistance
OmniSeq offers a robust financial assistance program to assist you in managing any patient responsibility for OmniSeq Comprehensive testing. An OmniSeq CARES specialist will help navigate the process by identifying the programs that you qualify for and assist you, where applicable, with enrollment.
Targeted Therapy Information
OmniSeq Comprehensive provides access to information about targeted therapies through our clinical report that is backed by the highest levels of evidence available. Our report is designed to identify the best possible therapies and help your doctor make the most therapeutically actionable treatment plan for your specific cancer.
OmniSeq CARES specialists are available to:
- Discuss what OmniSeq Comprehensive can do for you and your treatment plan
- Work with your doctor to facilitate testing with OmniSeq Comprehensive
- Answer your questions about insurance and financial assistance
- Help identify clinical trial opportunities
- Answer any additional questions
Frequently Asked Questions
on OmniSeq Products and Services
If you do not find the answer you are looking for, contact an OmniSeq CARES representative by phone
at 1-800-781-1259 or email us at email@example.com. We answer all customer support requests promptly.
What is “Precision Medicine”?
Precision medicine is a form of personalized medicine, where the treatment or regiment is tailored specifically to the individual patient and their biology.
What is a targeted therapy?
Target therapies are drugs, alone or in combination, that specifically targets a protein of interest or a unique biological function.
How are targeted therapies different from regular chemotherapy?
Targeted therapies, in contrast to traditional chemotherapy and radiation, can potentially be less toxic to you and may exhibit a better treatment response by only attacking cancer cells carrying your specific mutation.
Can OmniSeq Comprehensive be used for my tumor type?
OmniSeq Comprehensive can provide the molecular profile for any type of solid tumor.
How can I get tested with OmniSeq Comprehensive?
Only your doctor can order OmniSeq Comprehensive. A small portion of your tumor is needed to perform the test at the OmniSeq laboratory. This tissue may already be stored at the site where you had a previous surgery or biopsy. OmniSeq CARES will work with your healthcare team to facilitate testing and provide a detailed report about your cancer to your physician.
How can I learn more about participating in clinical trials?
The FDA is encouraging more patients to participate in clinical trials, especially people of different ages, races, ethnic groups, and genders. Overall, few people actually sign up for and participate in trials, and those who do participate don’t always represent the U.S. population. Participation is especially low for certain populations, including adults age 75 or older and people from certain racial and ethnic groups. Learn more here: http://www.fda.gov/ForPatients/ClinicalTrials/
What happens after the OmniSeq Comprehensive testing is completed?
Results of OmniSeq Comprehensive testing are returned directly to your doctor. The results include a detailed assessment of your tumor, as well as information about your cancer’s eligibility for targeted therapies or clinical trials.
Does OmniSeq bill my insurance?
OmniSeq will work with every insurance carrier to maximize coverage of OmniSeq testing regardless of participation status. We believe every patient should have access to OmniSeq testing regardless of insurance participation or financial status. Let the OmniSeq CARES team navigate the insurance claim process while you focus on your care.
OmniSeq is currently participating with the following insurances:
- NYS Medicaid
- USA Managed Care
Will my insurance cover OmniSeq Comprehensive?
Our customer service program, OmniSeq CARES, is dedicated to help you. The team works directly with your insurance carrier to maximize insurance coverage of OmniSeq testing. If necessary, our representatives will help you enroll in an assistance program that reduces your financial burden.
What if a targeted therapy is not approved for the treatment of my type of tumor?
OmniSeq CARES is your dedicated clinical trial access partner. Our team will help connect you to the clinical trial option that best suits your treatment needs.
What is a cancer clinical trial?
A clinical trial is a regulated study to evaluate if a novel therapy is more efficacious than the current standard of care for that specific cancer sub-type or targeted protein. Trials are conducted in “Phases”.
Exploratory studies involving very limited human exposure to the drug, with no therapeutic or diagnostic goals (for example, screening studies, microdose studies). The objective is to establish whether an intervention is affecting its target and whether further clinical development is warranted. Phase 0 trials are very small trials that help researchers decide if a new agent should be tested in a phase 1 trial.
Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine how an intervention should be administered, determine a safe dosage range, and identify side effects. They determine how the drug is metabolized and excreted.
Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance, called a placebo, or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.
The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Studies occurring after FDA has approved a drug for marketing to gather information on the drug’s effect in various populations and any side effects associated with long-term use. These including post-market requirement and commitment studies that are required of or agreed to by the study sponsor.